Opdivo, also known as nivolumab, represents a major advancement in malignancy care. It's a class of immune therapy, specifically a monoclonal antibody, designed to help your body's natural defenses attack tumors. Unlike traditional treatments that kill cancer cells, Opdivo functions by blocking a